Wockhardt · NSE: WOCKPHARMA · BSE: 532300

Q2 FY19 results · Jul–Sep 2018

Wockhardt reported revenue from operations of ₹1,125.68 crore and net loss of ₹30.84 crore for Q2 FY19 (Jul–Sep 2018), on a consolidated basis.

Consolidated · ₹ crore
ItemQ2 FY19Q2 FY18YoYQ1 FY19QoQ
Revenue from operations1,125.68——1,007.71+11.7%
Other income6.09——7.43−18.0%
Total income1,131.77——1,015.14+11.5%
Profit before tax(31.79)——(99.94)Loss narrowed
Net profit for the period(30.84)——(95.06)Loss narrowed
EPS, basic (₹)(2.06)——(7.79)Loss narrowed
Net margin (%)-2.7—-9.4
Standalone · ₹ crore
ItemQ2 FY19Q2 FY18YoYQ1 FY19QoQ
Revenue from operations634.59——539.36+17.7%
Other income8.38——8.33+0.6%
Total income642.97——547.69+17.4%
Profit before tax8.58——(16.88)Turned profit
Net profit for the period5.10——(15.11)Turned profit
EPS, basic (₹)0.46——(1.37)Turned profit
Net margin (%)0.8—-2.8
Consolidated
Filed with BSE
10 Nov 2018, 18:20 IST
Board meeting
10 Nov 2018
Period
01 Jul 2018 to 30 Sep 2018
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
10 Nov 2018, 18:20 IST
Board meeting
10 Nov 2018
Period
01 Jul 2018 to 30 Sep 2018
Review status
Unaudited
Source
XBRL filing on BSE